PL EN


Preferences help
enabled [disable] Abstract
Number of results
2001 | 49 | 4 | 293-302
Article title

Cytokine-based immunotherapy of allergic disease

Title variants
Languages of publication
EN
Abstracts
EN
Human immediate hypersensitivity diseases are strongly associated with an excessive type 2 response to normally innocuous environmental antigens, and are a growing health care concern in developed nations. Commonly prescribed treatments provide effective symptomatic relief, but are unable to consistently ameliorate the underlying cause of allergic disease: the excessive generation of allergen specific Th2 cells. IL-12 and IL-18 are potent inducers of type 1 immunity, and, as such, have been proposed as candidates for treatment of allergic diseases. This review critically assesses the potential of recombinant IL-12 and IL-18 immunotherapy to redirect both de novo and established allergic responses in animal models of human allergic disease to clinically protective immune responses.
Publisher

Year
Volume
49
Issue
4
Pages
293-302
Physical description
Contributors
References
Document Type
REVIEW
Publication order reference
I. P. Lewkowich, Department of Immunology, University of Manitoba, Winnipeg, Canada
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-4dabcd9d-a734-383c-9c31-53dd89692308
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.